• Localized Nerve Anesthesia a Viable Option for Pain Control in Pediatric SCD Patients, Study Suggests
  • Global Blood Expands Sickle Cell Study to Include Kids Ages 6-11
  • FDA Approves Endari, 1st Sickle Cell Treatment in Almost 20 Years, for Patients Age 5 and Older
  • Researchers Identify Genetic Predictors of Sickle Cell Anemia-Related Complications
  • European Agency Grants PRIME Access to GBT440 Therapy for Treatment of SCD
  • Chip-based Models Mimic Organs to Advance Understanding of Sickle Cell Disease
  • Moderate Exercise Training Improves Several SCD Features in Experimental Mice Models, Study Shows
  • Sickle Cell Disease Association of America Receives $11.6 Million Grant for Follow–Up Services
  • Psychological Factors Can Affect Pain Sensitivity in Pediatric SCD Patients, Study Finds
  • Researchers Compare PROMIS and ASCQ-Me to Measure SCD Disease Activity
  • Only 21% of Kids with ADHD and SCD Are Treated for Attention Deficit
  • New Pre-transplant Treatment Regimen Improves Survival of Kids with Sickle Cell Disease, Trial Shows